Feola S, Russo S, Martins B, Lopes A, Vandermeulen G, Flühler V, et al. Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine. Front Immunol. 2022;13:826164 pubmed publisher

Dobrica M, Lazar C, Paruch L, van Eerde A, Clarke J, Tucureanu C, et al. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice. Vaccine. 2018;36:5789-5795 pubmed publisher

Hjertner B, Bengtsson T, Morein B, Paulie S, Fossum C. A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine. Vaccine. 2018;36:3340-3344 pubmed publisher

Magnusson S, Altenburg A, Bengtsson K, Bosman F, de Vries R, Rimmelzwaan G, et al. Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice. Immunol Res. 2018;66:224-233 pubmed publisher

Stavaru C, Onu A, Lupulescu E, Tucureanu C, Raşid O, Vlase E, et al. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant. Hum Vaccin Immunother. 2016;12:1009-26 pubmed publisher